Bendamustine Dimer 2-Allyl Ester
It chemical group organic compound is associate impurity of Bendamustine. Bendamustine may be a therapy medication utilized in the treatment of chronic leukemia (CLL), myeloma, and non-Hodgkin’s malignant neoplastic disease.
Additional information on Bendamustine Dimer 2-Allyl Ester
Catalogue No.
VE007308
CAS No.
N/A
Molecular Formula
C35H45Cl3N6O4
Molecular Weight
720.13 g/mol
Parent drug
Bendamustine
IUPAC Name
4-(5-((2-((4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate allyl ester
Synonyms
N/A
References
“Sci-Hub, Determination and Characterization of Two Degradant Impurities in Bendamustine Hydrochloride Drug Product, 10.1093/Chromsci/Bmv070.” Hkvisa.net, 2015, sci-hub.hkvisa.net/10.1093/chromsci/bmv070.
Status
In-stock
